NCT05646056Completed
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
A Noninterventional, Single-Center Feasibility Study to Evaluate Longitudinal Measures of Heart Failure Risk Using the Pyxida System
Source: ClinicalTrials.gov · Last updated 24 Oct 2024
Brief summary (registry, in English)
This is a non-invasive/observational study in healthy and mild HF subjects utilizing clinical and ambulatory measurements to improve detection, monitoring, and management of HF risks.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 82 (actual)
- First submitted
- 23 Nov 2022
- Start date
- 28 Oct 2022
- Primary completion date
- 18 Sept 2024
- Lead sponsor
- Prolaio
- Diseases
- Heart failure, Hypertrophic cardiomyopathy
- NCT number
- NCT05646056
What you commit to
- Study type: Observational
- Participants enrolled: 82
- From 28 Oct 2022 to the primary completion date, 18 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active neurological disorder, such as uncontrolled seizure disorder.
- Current diagnosis of cancer or other known acute chronic infection, such as hepatitis B or hepatitis C, by medical history or an active infection requiring interventional therapy at screening.
- Shortness of breath, fatigue, heart palpitations, pain, or other limitations of physical activity
Who the study is looking for
- Cohort 2: Confirmed medical history of LVH based on American College of Cardiology (ACC)/American Heart Association (AHA) guidelines and NYHA Class I at screening
- Cohort 3: Confirmed medical history of HF consistent with current ACC/AHA guidelines and NYHA Class I at screening
- Cohort 4: Confirmed medical history of HCM consistent with ACC/AHA guidelines and NYHA Class I or II at screening
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jacksonville Center for Clinical Research Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.